Evaluation of procollagen-III peptide as a marker for veno-occlusive disease after bone marrow transplantation

Annals of Hematology

Volumn 73, Issue 1, 1996, Pages 25-28

  Schuler, U ^a   Subat, S ^a   Schmidt, H ^b   Schneider, A ^a   Ehninger, G ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

BMT complications; Diagnosis; Procollagen III peptide; Veno occlusive disease of the liver

Indexed keywords

BIOCHEMICAL MARKER; PROCOLLAGEN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEVER; GRAFT VERSUS HOST REACTION; HUMAN; INTERSTITIAL PNEUMONIA; LIVER VEIN OBSTRUCTION; LUNG FIBROSIS; LYMPHOMA; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ADULT; BIOLOGICAL MARKERS; BONE MARROW TRANSPLANTATION; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; PEPTIDE FRAGMENTS; PROCOLLAGEN; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0030036385     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050194     Document Type: Article

References (20)

1. Abdel-Aziz MT, Abdel-Aziz-Wassef M, Kamel M, el-Zein M, el-Hassan H (1993) Clinical evaluation of serum aminoterminal propeptide of type III procollagen as tumor marker in gynecologic malignancies. Tumori 79:219-223
2. Aresu G, Pascalis L, Pia G (1990) Behavior of blood copper, ceruloplasmin and procollagen III in acute myocardial infarction. Minerva Cardioangiol 38:141-150
3. Bearman SI, Shuhart MC, Hinds MS, McDonald GB (1992) Recombinant human tissue plasminogen activator for the treatment of established severe veno occlusive disease of the liver after bone marrow transplantation. Blood 80:2458-2462
4. Eltumi M, Trivedi P, Hobbs JR, Portmann B, Cheeseman P, Downie C, Risteli J, Risteli L, Mowat AP (1993) Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen. Lancet 342:518-521
5. Entzian P, Huckstadt A, Kreipe H, Barth J (1990) Determination of serum concentrations of type III procollagen peptide in mechanically ventilated patients. Pronounced augmented concentrations in the adult respiratory distress syndrome. Am Rev Respir Dis 142:1079-1082
6. Farjanel J, Hartmann DJ, Guidet B, Luquel L, Offenstadt G (1993) Four markers of collagen metabolism as possible indicators of disease in the adult respiratory distress syndrome. Am Rev Respir Dis 147:1091-1099
7. Gabazza EC, Taguchi O, Yamakami T, Machishi M, Ibata H, Tsutsui K, Suzuki S (1992) Coagulation-fibrinolysis system and markers of collagen metabolism in lung cancer. Cancer 70:2631-2636
8. Heikinheimo M, Halila R, Fasth A (1994) Serum procollagen type III is an early and sensitive marker for veno-occlusive disease of the liver in children undergoing bone marrow transplantation. Blood 83:3036-3040
9. Hertenstein B, Wolf C, Bunjes D, Wennauer R, Wiesneth M, Novotny J, Heimpel H, Arnold R (1995) Value of procollagen-III-N-peptide (PIIINP) serum levels in diagnosis of hepatic venoocclusive disease (VOD) after allogeneic bone marrow transplantation in adults. Bone Marrow Transplant 15[Suppl 2]:S149
10. McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED (1984) Veno-occlusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 4:116-122
11. Oikarinen A, Autio P, Vuori J, Vaananen K, Risteli L, Kiistala U, Risteli J (1992) Systemic glucocorticoid treatment decreases serum concentrations of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen. Br J Dermatol 126:172-178
12. Reilly JT, Barnett D, Dolan G, Forrest P, Eastham J, Smith A (1993) Characterization of an acute micromegakaryocytic leukaemia:evidence for the pathogenesis of myelofibrosis. Br J Haematol 83:58-62
13. Rio B, Bauduer F, Arrago JP, Zittoun R (1993) N-terminal peptide of type III procollagen: a marker for the development of hepatic veno-occlusive disease after BMT and a basis for determining the timing of prophylactic heparin. Bone Marrow Transplant 11:471-472
14. Salat C, Holler E, Reinhardt B, Kolb HJ, Pihusch R, Neumeister P, Hiller E (1994) Hypercoagulability in patients with veno-occlusive disease after bone marrow transplantation. Med Klin 89:245-247
15. Schuler U, Schroer S, Kuhnle A, Blanz J, Mewes K, Proksch B, Zeller K-P, Ehninger G (1994) Busulfan pharmacokinetics in BMT patients: is drug monitoring warranted? Bone Marrow Transplant 14:759-765
16. Taube T, Franssila K, Risteli L, Risteli J, Elomaa I (1992) Monitoring of multiple myeloma and bone marrow fibrosis with aminoterminal propeptide of type III collagen (PIIINP). Br J Haematol 82:32-37
17. Vainionpaa L, Risteli L, Lanning M, Myllyla V, Risteli J (1991) Aminoterminal propeptide of type III procollagen in cerebrospinal fluid. Variation with age and in childhood leukemia. Clin Chim Acta 203:47-56
18. Whitehair KJ, Parker JE, Smith GNJ, Adams SB, Bottoms GB (1991) Serum levels of type III procollagen peptide in Equidae before and after intestinal ischemia. Vet Surg 20:311-315
19. Yu LC, Malkani I, Regueira O, Ode DL, Warrier RP (1994) Recombinant tissue plasminogen activator (rt-PA) for venoocclusive liver disease in pediatric autologous bone marrow transplant patients. Am J Hematol 46:194-198
20. Yudoh K, Matsui H, Kanamori M, Ohmori K, Tsuji H, Tatezaki S (1994) Serum levels of laminin, type IV collagen and type III procollagen peptide as markers for detection of metastasis. Jpn J Cancer Res 85:1263-1269